What Are the Short-term Benefits and Potential Harms of Therapeutic Modalities for the Management of Overactive Bladder Syndrome in Women? A Review of Evidence Under the Auspices of the European Association of Urology, Female Non-neurogenic Lower Urinary Tract Symptoms Guidelines Panel-Reference-Cited by-同舟云学术

What Are the Short-term Benefits and Potential Harms of Therapeutic Modalities for the Management of Overactive Bladder Syndrome in Women? A Review of Evidence Under the Auspices of the European Association of Urology, Female Non-neurogenic Lower Urinary Tract Symptoms Guidelines Panel

Published:2023-09 Issue:3 Volume:84 Page:302-312
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Farag Fawzy,Sakalis Vasileios I.,Arteaga Serenella Monagas,Sihra Néha,Karavitakis Markos,Arlandis Salvador,Bø Kari,Cobussen-Boekhorst Hanny,Costantini Elisabetta,de Heide Monica,Groen Jan,Peyronnet Benoit,Phé Veronique,van Poelgeest-Pomfret Mary-Lynne,van den Bos Tine W.L.,van der Vaart Huub,Harding Christopher K.,Carmela Lapitan Marie,Imran Omar Muhammad,Nambiar Arjun K.

Publisher

Elsevier BV

Subject

Urology

Reference66 articles.

1. Do we need a new definition of the overactive bladder syndrome? ICI-RS 2013;Drake;Neurourol Urodyn,2014

2. Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006;50:1306–14; discussion 1314–5.

3. Prevalence and risk factors of urinary incontinence and overactive bladder in Japanese women;Ninomiya;Low Urin Tract Symptoms,2018

4. Global prevalence and economic burden of urgency urinary incontinence: a systematic review;Milsom;Eur Urol,2014

5. Prevalence of the overactive bladder syndrome by applying the international continence society definition;Temml;Eur Urol,2005

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The history of the pharmacologic treatment of urgency incontinence;Continence Reports;2024-09

2. Efficacy of the combination of transcutaneous tibial nerve stimulation(TTNS) and mirabegron in women with overactive bladder: a prospective randomized controlled trial;2024-07-29

3. A high salt diet impairs the bladder epithelial barrier and activates the NLRP3 and NF‑κB signaling pathways to induce an overactive bladder in vivo;Experimental and Therapeutic Medicine;2024-07-12

4. Polo‐like kinase 1 inhibition modulates urinary tract smooth muscle contraction and bladder cell transcriptional programs;Cytoskeleton;2024-07-12

5. Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial;World Journal of Urology;2024-05-13